Publications by authors named "Masaaki Arima"

Background: Patients on maintenance hemodialysis (HD) have much higher levels of adiponectin (Total-APN). Adiponectin and C1q form a protein complex in human blood, and serum C1q-binding adiponectin (C1q-APN) can be measured. We recently reported that C1q-APN/Total-APN ratio rather than Total-APN correlated with atherosclerosis in diabetics.

View Article and Find Full Text PDF

Thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) are enzymes involved in the metabolism of 5-fluorouracil (FU). To investigate the relationship of these activities with clinicopathological factors and survival, we measured TS (88 patients) and DPD (122 patients) activities in resected specimens of breast cancer by enzyme assay. Significant difference was found only in TS activity between tumors > or = 20 mm in diameter and those < 20 mm (p = 0.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Masaaki Arima"

  • Masaaki Arima's research encompasses the exploration of biomarker interactions in chronic conditions, particularly focusing on adiponectin's role in hemodialysis patients and its implications for atherosclerosis.
  • His study on serum C1q-binding adiponectin revealed that the C1q-APN/Total-APN ratio is a more reliable indicator of atherosclerotic changes in diabetics than Total-APN levels alone.
  • Arima also investigated the prognostic significance of metabolic enzymes in breast cancer treatment, specifically analyzing thymidylate synthase and dihydropyrimidine dehydrogenase for their potential correlations with patient outcomes following 5-fluorouracil chemotherapy.